AH Lisanti Capital Growth »

Travere Therapeutics shares owned by AH Lisanti Capital Growth

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by AH Lisanti Capital Growth from 13F filings

Historical chart of AH Lisanti Capital Growth investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by AH Lisanti Capital Growth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by AH Lisanti Capital Growth

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1M 130k 23.90

More positions owned by AH Lisanti Capital Growth

Kratos Defense & Sec Solutio Com New (KTOS)
Sterling Construction Company (STRL)
Bwx Technologies (BWXT)
Modine Manufacturing (MOD)
Biosante Pharmaceuticals (ANIP)
Mercury Computer Systems (MRCY)
Construction Partners Com Cl A (ROAD)
Zeta Global Holdings Corp Cl A (ZETA)
Ban (TBBK)
American Superconductor Corp Shs New (AMSC)
John Bean Technologies Corporation (JBTM)
Boot Barn Hldgs (BOOT)
Impinj (PI)
Mp Materials Corp Com Cl A (MP)
Transmedics Group (TMDX)

View all positions for AH Lisanti Capital Growth

Top funds holding Travere Therapeutics

Henderson Group
BlackRock
Armistice Capital
Vanguard Group
Macquarie Group
Perceptive Advisors
Adage Capital Partners GP
State Street Corporation
FMR
Rock Springs Capital Management
Emerald Advisers
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Deutsche Bank Aktiengesellschaft

View all funds holding Travere Therapeutics